Advancing Telemedicine Outreach within a Comprehensive Cancer Center: Lessons Learned from Rapid Transformation of Care Practice and Operational Changes Associated with the COVID-19 Pandemic

Page 1 of 6: Front Matter


Program Overview
The COVID-19 pandemic has brought significant changes to the delivery of healthcare while increasing care needs in certain areas. In this article, the authors present the journey their comprehensive cancer center underwent to implement telemedicine service for a short period during the COVID-19 pandemic, lessons learned from the process, and future directions for telemedicine use in cancer care.

Target Audience
This educational initiative is intended for hematology/oncology nurse navigators, patient navigators, and social workers whose focus is on cancer care and survivorship. It will also be useful for nurse practitioners, oncology nurses, advanced practice nurses, and other healthcare professionals involved in managing patients with cancer.

Learning Objectives
Upon completion of this webinar, participants should be able to:

  • Identify at least 2 direct impacts of the COVID-19 pandemic on cancer patents and survivors
  • Explain benefits of using telemedicine to deliver care to cancer patients
  • List at least 2 strategies for successful implementation of telemedicine in cancer centers
  • Describe barriers for implementing telemedicine in your practice

CE Credit jointly provided by AKH, Inc., Advancing Knowledge in Healthcare and Center of Excellence Media, LLC.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Center of Excellence Media, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit being awarded: 1.0 ANCC contact hours.

Featured Faculty

Faculty Disclosures
Name Relationship Company

Nick Jaidar, FACHE, MHA
Director, Oncology Operations
University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD

N/A Nothing to disclose

Eun-Shim Nahm, PhD, RN, FAAN
Program Director, Nursing Informatics
University of Maryland School of Nursing
Baltimore, MD

N/A Nothing to disclose

Heather Thomas, CMA (AAMA)
Business Operations Manager
University of Maryland Medical Center Greenebaum Comprehensive Cancer Center
Baltimore, MD

N/A Nothing to disclose
Planner Disclosures
Name Relationship Company
Dorothy Caputo, MA, BSN, RN - CE Director of Accreditations N/A Nothing to disclose
Bernadette M. Makar, MSN, APRN, BC, NP-C (Reviewer) N/A Nothing to disclose
Center of Excellence Media, LLC – An affiliate of The Lynx Group N/A Nothing to disclose
AKH Planners and Reviewers N/A Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.

Criteria for Success
Statements of credit will be awarded based on the participant's reading the monograph, participation in the post-test and submission of the activity evaluation form. A statement of credit will be available upon completion of the post-test and online evaluation/claimed credit form at the end of the activity.

If you have questions about this CE activity, please contact AKH Inc. at


CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Commercial Support
There is no commercial support for this activitya.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link